logo
Singapore nurse faces close to a million dollars in medical bills after long-awaited baby is born premature at 25 weeks

Singapore nurse faces close to a million dollars in medical bills after long-awaited baby is born premature at 25 weeks

SINGAPORE: A Singapore nurse and his wife have made a public appeal for help as their newborn daughter fights for survival in the Neonatal Intensive Care Unit (NICU) at the National University Hospital (NUH), after being born prematurely at just 25 weeks of gestation.
Born on 26 June, baby Chelsea weighed a mere 365 grams. Her mother, Carol, described the birth as a moment of desperate hope and fear, after a pregnancy plagued by complications.
'She is now fighting for her life in the NICU, surrounded by machines, tubes, and prayers,' Carol wrote in an appeal on the Give.Asia platform, 'Every moment is critical. Every breath she takes is a miracle.'
Carol works as a clinic secretary while her husband Ehrol has served as a staff nurse in Singapore for the past seven years. In 2023, the couple were granted Singapore Permanent Residency and earlier this year, Carol learned she was pregnant.
Carol, however, ended up getting diagnosed with intrauterine growth restriction and placental complications. Her pregnancy was classified as high-risk, and doctors at NUH closely monitored her condition.
On 25 June, Carol began bleeding heavily and she was rushed into an emergency delivery due to severe preeclampsia and placental abruption. Chelsea arrived far too early, in critical condition.
The infant cannot breathe on her own and is reliant on invasive mechanical ventilation. Diagnosed with pulmonary immaturity, respiratory distress, and pulmonary hypertension, she requires constant, high-level medical intervention, including inhaled nitric oxide therapy, parenteral nutrition, and regular blood transfusions.
Doctors estimate that Chelsea will need to remain in the NICU for six to nine months.
Despite both parents working in healthcare and being Permanent Residents, they are only eligible for limited medical subsidies. The projected cost of Chelsea's care is staggering: S$920,000.
'We are doing everything we can,' Carol said, 'But the cost of saving her life is beyond our means.'
The couple is now turning to the public for support. With the help of Give.Asia, they have launched a fundraiser to cover Chelsea's medical costs, starting with an initial goal of S$92,000 — just 10% of the full projected amount.
'Chelsea didn't choose to come into this world so early — but she's here, and she's fighting,' Carol wrote, 'We believe that her story isn't just one of struggle, but of hope, strength, and miracles.'
The family is urging Singaporeans and members of the international community to contribute, share their story, and help keep Chelsea's care uninterrupted. They said, 'All funds raised will go directly to NUH via Give.Asia. Every cent helps, and every share could reach someone who might help save her life.'
'Your kindness could mean everything to a tiny girl who's already braver than most adults will ever be,' Carol said.
Those interested in donating or learning more can visit their Give.Asia fundraising page.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Oxford study linking vaccines to lower dementia risk needs more evidence, say Singapore doctors
Oxford study linking vaccines to lower dementia risk needs more evidence, say Singapore doctors

CNA

time4 hours ago

  • CNA

Oxford study linking vaccines to lower dementia risk needs more evidence, say Singapore doctors

SINGAPORE: A recent Oxford study suggesting that certain vaccines may help reduce the risk of dementia has drawn interest from medical professionals in Singapore, but they said the findings are still too preliminary to influence clinical practice. Released in June, the study analysed health data from nearly 437,000 individuals in the United States. It found that those who received either the shingles vaccine or the respiratory syncytial virus (RSV) vaccine – both of which contain the AS01 adjuvant – had a lower risk of developing dementia within 18 months. Specifically, the RSV vaccine, Arexvy, was associated with a 29 per cent reduction in risk, while the shingles vaccine, Shingrix, was linked to an 18 per cent reduction. Researchers believe the AS01 adjuvant, a substance used to enhance immune response, may be the key factor behind this potential benefit. 'It gives us a possible explanation that the secret recipe may lie in the adjuvant,' said Dr Philip Yap, a senior consultant in geriatric medicine at Khoo Teck Puat Hospital. 'The adjuvant is actually given in these recombinant vaccines to boost its efficacy,' he said. 'When you give an adjuvant, the vaccine is supposed to elicit a stronger immune response, like a booster.' EVIDENCE STILL 'TOO WEAK' Despite these encouraging findings, Dr Yap and other dementia specialists in Singapore stressed that the results should be interpreted cautiously. Dr Chong Yao Feng, a consultant in the neurology division at the National University Hospital, said that while the study was 'well done', it was epidemiological in nature – based on observational data rather than randomised controlled trials. 'The nature of epidemiological studies is that they demonstrate associations but not causations, unlike randomised controlled trials.' He expressed concerns about how the study would be interpreted and whether it could influence actions by individual patients or by health authorities. "We cannot repurpose shingles or RSV vaccines for dementia prevention on the basis of this study alone," Dr Chong said. "Neither should individual patients sign up for these vaccinations with the belief that their risk of dementia is reduced. The current evidence is too weak for such actions to be taken." Others said that longer-term studies are necessary before drawing firm conclusions, particularly since the effects of introducing these vaccines into the immune system need to be carefully examined. Dr Zhao Yi Jing, a neurologist at Mount Elizabeth Hospital, said the 18-month window observed in the study is too short to assess long-term effects on a condition like dementia, which often takes decades to develop. The pathological process of dementia can begin 10 to 20 years before clinical symptoms appear. The study does not provide enough evidence to show that the vaccines can prevent dementia or slow its progression in patients, she said. Still, Dr Zhao acknowledged that the idea is not without precedent. Other vaccines have been used to treat other diseases, such as the hepatitis vaccine being used to prevent liver cancer. 'It's still too early to tell, but it's not like it hasn't happened before. But when you do that, there are a lot of ethical regulatory considerations,' she added. Khoo Teck Puat Hospital's Dr Yap, who also chairs social service agency Dementia Singapore, echoed her sentiments. "It is really too premature, it's still too early. There are positive signals that warrant further investigation. So these positive signals shouldn't be ignored, but neither should we take them to be confirmatory," he said. 'We need more studies to understand whether future studies can replicate the same findings. So the more studies we have, that means the evidence becomes stronger and more robust.' Dr Yap warned that while an enhanced immune response might help clear amyloid plaques – proteins implicated in Alzheimer's disease – it could also provoke chronic inflammation. 'You want to remove the bad amyloid, the toxic substances. But at the same time, you do not want damage to the good cells,' he said. PREVENTING DEMENTIA Beyond vaccines, doctors highlighted well-established methods for lowering dementia risk. These include regular exercise, mental stimulation and a balanced diet. Preserving hearing and vision is also increasingly recognised as important. 'It has been shown that hearing loss increases the risk of dementia by up to two times,' said Dr Yap, advising people to consider hearing aids and 'not neglect things' that can be easily addressed. He also advised those with poor vision due to cataracts to get it treated – "quite a simple, low-risk surgery" – instead of living with the problem. Sleep and alcohol consumption are also risk factors. Poor sleep can disrupt the brain's glymphatic system, which is crucial for clearing toxic substances like amyloid plaques, said Dr Yap. Mount Elizabeth's Dr Zhao added that high alcohol consumption can trigger a general inflammatory response in the body and direct neurotoxicity. 'I have seen patients where through chronic alcoholism, their brain has gone through significant shrinkage compared to other people of their age who don't drink a lot of alcohol,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store